11 min listen
The Lancet: March 25, 2008
ratings:
Length:
13 minutes
Released:
Mar 25, 2008
Format:
Podcast episode
Description
Josef Smolen from the Medical University of Vienna, Austria, discusses in this week's podcast how the monoclonal antibody tocilizumab could be effective in treating rheumatoid arthritis. Tocilizumab blocks interleukin 6, a pro-inflammatory cytokine involved in the biological process behind rheumatoid arthritis
Released:
Mar 25, 2008
Format:
Podcast episode
Titles in the series (100)
The Lancet: October 13, 2006 by The Lancet in conversation with